A phase II trial to evaluate the epithelial-to-mesenchymal (EMT) inhibitor sotevtamab combined with docetaxel in patients with metastatic non-small cell lung cancer following failure of primary chemoimmunotherapy
Blais, Normand, Cournoyer, Ghislain, Dionne, Jean-Luc, Labbe, Catherine, Gaboury, Louis, Trinh, Vincent Quoc-Huy, Burnier, Julia V., Bartolomucci, Alexandra, Viau, Elisabeth, Laurin, Julie, Filion, Mario, Jolivet, Jacques, Byers, Lauren Averett
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Abstract LB-297: The EMT inhibitor AB-16B5 interacts with specific isoforms of secreted clusterin
Tremblay, Gilles B., Viau, Elisabeth, Filion, Mario
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates
Guimond, Alain, Viau, Elisabeth, Aubé, Paméla, Renzi, Paolo M, Paquet, Luc, Ferrari, Nicolay
Published in Pulmonary pharmacology & therapeutics (01.12.2008)
Published in Pulmonary pharmacology & therapeutics (01.12.2008)
Get full text
Journal Article
Abstract LB-33: Pre-clinical evaluation of AB-16B5, a monoclonal antibody specific for tumor-associated sCLU, demonstrates therapeutic potential as an inhibitor of EMT in prostate, pancreatic and lung cancer
Tremblay, Gilles B., Viau, Elisabeth, Malouin, Mireille, Turcotte, Émilie, Fortin, Annie, Filion, Mario
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article